News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
730,769 Results
Type
Article (41354)
Company Profile (264)
Press Release (689135)
Multimedia
Podcasts (91)
Webinars (20)
Section
Business (204841)
Career Advice (2032)
Deals (35582)
Drug Delivery (128)
Drug Development (81516)
Employer Resources (173)
FDA (16510)
Job Trends (14982)
News (346823)
Policy (32750)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2595)
Accelerated approval (47)
Adcomms (26)
Allergies (171)
Alliances (49579)
ALS (210)
Alzheimer's disease (1796)
Antibody-drug conjugate (ADC) (446)
Approvals (16893)
Artificial intelligence (660)
Autoimmune disease (290)
Automation (56)
Bankruptcy (362)
Best Places to Work (11635)
BIOSECURE Act (20)
Biosimilars (221)
Biotechnology (173)
Bladder cancer (194)
Brain cancer (71)
Breast cancer (749)
Cancer (5810)
Cardiovascular disease (469)
Career advice (1724)
Career pathing (42)
CAR-T (331)
CDC (56)
Celiac Disease (3)
Cell therapy (897)
Cervical cancer (47)
Clinical research (70815)
Collaboration (2050)
Company closure (5)
Compensation (1394)
Complete response letters (80)
COVID-19 (2741)
CRISPR (107)
C-suite (1119)
Cystic fibrosis (152)
Data (7877)
Decentralized trials (3)
Denatured (27)
Depression (161)
Dermatology (86)
Diabetes (586)
Diagnostics (6927)
Digital health (54)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (316)
Drug pricing (200)
Drug shortages (31)
Duchenne muscular dystrophy (283)
Earnings (92104)
Editorial (66)
Employer branding (21)
Employer resources (152)
Events (119488)
Executive appointments (1079)
FDA (20230)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (18)
Frontotemporal dementia (34)
Funding (1719)
Gene editing (233)
Generative AI (56)
Gene therapy (720)
GLP-1 (1052)
Government (4731)
Grass and pollen (6)
Guidances (408)
Healthcare (18996)
HIV (79)
Huntington's disease (56)
IgA nephropathy (97)
Immunology and inflammation (287)
Immuno-oncology (93)
Indications (194)
Infectious disease (3078)
Inflammatory bowel disease (216)
Inflation Reduction Act (14)
Influenza (136)
Intellectual property (288)
Interviews (319)
IPO (16667)
IRA (50)
Job creations (3647)
Job search strategy (1430)
JPM (58)
Kidney cancer (19)
Labor market (100)
Layoffs (562)
Leadership (39)
Legal (7953)
Liver cancer (100)
Longevity (32)
Lung cancer (762)
Lymphoma (429)
Machine learning (60)
Management (59)
Manufacturing (1045)
MASH (186)
Medical device (13929)
Medtech (14051)
Mergers & acquisitions (20160)
Metabolic disorders (1496)
mRNA (204)
Multiple sclerosis (187)
NASH (17)
Neurodegenerative disease (414)
Neuropsychiatric disorders (105)
Neuroscience (3300)
Neurotech (1)
NextGen: Class of 2026 (6520)
Non-profit (4530)
Now hiring (78)
Obesity (700)
Opinion (287)
Ovarian cancer (220)
Pain (253)
Pancreatic cancer (300)
Parkinson's disease (360)
Partnered (33)
Patents (593)
Patient recruitment (667)
Peanut (62)
People (59577)
Pharmaceutical (59)
Pharmacy benefit managers (32)
Phase 1 (22076)
Phase 2 (31201)
Phase 3 (23213)
Pipeline (8734)
Policy (316)
Postmarket research (2569)
Preclinical (9408)
Press Release (64)
Prostate cancer (303)
Psychedelics (54)
Radiopharmaceuticals (323)
Rare diseases (1073)
Real estate (5969)
Recruiting (70)
Regulatory (25392)
Reports (56)
Research institute (2412)
Resumes & cover letters (353)
Rett syndrome (39)
RNA editing (21)
RSV (88)
Schizophrenia (176)
Series A (288)
Series B (213)
Service/supplier (11)
Sickle cell disease (112)
Special edition (23)
Spinal muscular atrophy (166)
Sponsored (48)
Startups (3639)
State (2)
Stomach cancer (18)
Supply chain (126)
Tariffs (87)
The Weekly (62)
Vaccines (1088)
Venture capital (108)
Weight loss (450)
Women's health (127)
Worklife (20)
Date
Today (114)
Last 7 days (839)
Last 30 days (3431)
Last 365 days (30102)
2026 (12521)
2025 (30171)
2024 (35209)
2023 (40072)
2022 (51173)
2021 (55707)
2020 (54081)
2019 (46537)
2018 (35015)
2017 (32107)
2016 (31479)
2015 (37551)
2014 (31319)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (741)
Alabama (93)
Alaska (7)
Arizona (348)
Arkansas (14)
Asia (39669)
Australia (6506)
California (13265)
Canada (3764)
China (1335)
Colorado (566)
Connecticut (577)
Delaware (407)
Europe (85841)
Florida (1984)
Georgia (425)
Hawaii (3)
Idaho (62)
Illinois (1050)
India (90)
Indiana (599)
Iowa (23)
Japan (538)
Kansas (131)
Kentucky (50)
Louisiana (40)
Maine (76)
Maryland (1589)
Massachusetts (9457)
Michigan (363)
Minnesota (716)
Mississippi (6)
Missouri (144)
Montana (33)
Nebraska (29)
Nevada (143)
New Hampshire (84)
New Jersey (3491)
New Mexico (29)
New York (3469)
North Carolina (1683)
North Dakota (9)
Northern California (6648)
Ohio (396)
Oklahoma (23)
Oregon (41)
Pennsylvania (2670)
Puerto Rico (29)
Rhode Island (50)
South America (1112)
South Carolina (86)
South Dakota (2)
Southern California (5236)
Tennessee (211)
Texas (2110)
United States (46783)
Utah (394)
Vermont (1)
Virginia (321)
Washington D.C. (80)
Washington State (1061)
West Virginia (4)
Wisconsin (125)
Wyoming (2)
730,769 Results for "psychogenics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
PsychoGenics Launches an Updated Corporate Identity and Brand
PsychoGenics Inc., the leading contract research organization specializing in central nervous system focused preclinical and translational drug discovery services, is proud to unveil its refreshed corporate identity and brand.
November 10, 2023
·
2 min read
Pharm Country
PsychoGenics Announces Exclusive Global License for an IND-Ready ENT1 Inhibitor for the Treatment of Neuropsychiatric Disorders
PGI Drug Discovery LLC (PsychoGenics), a phenotypic drug discovery platform company, announced that it has entered into an exclusive license agreement with Roche to obtain global development, manufacturing, and commercialization rights to RO7117997. RO7117997, is an IND-ready Equilibrative Nucleoside Transporter 1 (ENT1) inhibitor discovered in partnership with Roche using the PsychoGenics’ AI-enabled phenotypic screening platforms.
December 1, 2023
·
3 min read
Press Releases
PsychoGenics Awarded an NIH Contract to Test and Identify Novel Therapeutics for Pain
October 8, 2024
·
2 min read
Pharm Country
PsychoGenics and Collaborations Pharmaceuticals awarded a $1M grant to use AI platforms to design new drugs for mental health disorders
PsychoGenics Inc. and Collaborations Pharmaceuticals, Inc. are pleased to announce that they were awarded a $1million Phase I Small Business Innovation Research grant, to use their combined AI tools to design new drugs for mental health disorders.
September 5, 2023
·
4 min read
Press Releases
Stonegate Initiates Coverage on StimCell Energetics Inc. (STME)
May 15, 2026
·
1 min read
Press Releases
Zivo Bioscience, Inc. Announces Transition to OTCID Marketplace
May 13, 2026
·
3 min read
Press Releases
Exagen Inc. Reports First Quarter 2026 Results
May 11, 2026
·
10 min read
Press Releases
Merck Completes Acquisition of Terns Pharmaceuticals, Inc.
May 5, 2026
·
6 min read
Press Releases
Pharmazz, Inc. Appoints Ajay Bansal as Chief Financial Officer
May 14, 2026
·
4 min read
Press Releases
COSCIENS Biopharma Inc. Reports Q1 2026 Results
May 13, 2026
·
8 min read
1 of 73,077
Next
